Erythrocytes are attractive as potential cell-based drug carriers because of their abundance and long lifespan in vivo. Existing methods for loading drug cargos into erythrocytes include hypotonic treatments, electroporation, and covalent attachment onto the membrane, all of which require ex vivo manipulation. Here, we characterized the properties of amphiphilic gold nanoparticles (amph-AuNPs), comprised of a ~2.3 nm gold core and an amphiphilic ligand shell, which are able to embed spontaneously within erythrocyte membranes and might provide a means to load drugs into red blood cells (RBCs) directly in vivo. Particle interaction with RBC membranes occurred rapidly at physiological temperature. We further show that amph-AuNP uptake by RBCs was limited by the glycocalyx and was particularly influenced by sialic acids on cell surface proteoglycans. Using a reductionist model membrane system with synthetic lipid vesicles, we confirmed the importance of membrane fluidity and the glycocalyx in regulating amph-AuNP/membrane interactions. These results thus provide evidence for the interaction of amph-AuNPs with erythrocyte membranes and identify key membrane components that govern this interaction, providing a framework for the development of amph-AuNP-carrying erythrocyte 'pharmacytes' in vivo.
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Accepted Manuscript Nanoscale www.rsc.org/nanoscale Introduction another widely used technique, particularly for large molecular weight or highly charged cargoes that cannot passively transit the membrane. [28] [29] [30] As an alternative to cargo encapsulation within a cell, there are also studies in which cargo molecules have been bound covalently to erythrocyte membranes. Using this technique, erythrocytes have specifically served to deliver vaccine antigens, with delivery of HIV-1 TAT protein being a key example.
31,32
Gold nanoparticles with organic ligand shells are being explored as candidate drug delivery agents that can carry drugs sequestered within their organic layer, bound reversibly to the gold core, or anchored to the ligand shell.
33-36
Motivated by the potential for such inorganic/organic hybrid nanomaterials to carry therapeutics, here we characterized water-soluble amphiphilic nanoparticles that partition into erythrocyte membranes without the need for membrane perturbation or manipulation, which we hypothesize could be loaded with drugs for direct association with erythrocytes. Using a one-step reaction, we synthesized small ~2-4 nm core size gold nanoparticles (amphAuNPs) with an amphiphilic ligand shell comprised of two alkanethiols. 37 Each amphAuNP was coated by a mixture of long-chain mercaptoundecanesulfonate (MUS), an eleven-carbon ligand terminated by a water-soluble sulfonate group, and short-chain hydrophobic octanethiol (OT, Fig. 1a ). Our previous studies have shown that MUS:OT amph-AuNPs can enter a variety of cells under conditions in which endocytosis has been blocked. [38] [39] [40] [41] We have also shown that they can carry oligonucleotide cargos into tumor cells under these conditions. 42 Notably, particle entry into cells was observed without any experimental evidence of membrane poration or disruption. These studies suggest that amph-AuNPs can enter cells passively, likely via a membrane interaction, resistant to protein adsorption; dynamic light scattering (DLS), TEM, and zeta potential analysis all confirmed that there were no changes in amph-AuNP size or charge when incubated in medium with and without serum. 38 We prepared 2:1 MUS:OT amph-AuNPs 2.3 ± 1.0 (st. dev.) nm in diameter Fig. 1a, SI Fig. 1a & SI Table 1 ) labeled with an alkanethiol-BODIPY fluorescent dye by a place exchange reaction to track the particles' interactions with cells as previously described. 49 When human erythrocytes were co-incubated with the membrane-impermeable dye calcein and BODIPY-labeled amph-AuNPs at 37°C for 3
hours, confocal micrographs showed that calcein remained extracellular, but the gold particles distinctly associated with the plasma membranes of the cells (Fig. 1b) . This particle signal was low but clearly detectable, and appeared confined to the plasma Table 1 ) associated with erythrocytes as quickly as 5 min at 37°C, with particle uptake increasing rapidly over the first 3 hours and continuing over 24 hr albeit more gradually (Fig. 1e) . To assay for the stability of amph-AuNP incorporation into RBC membranes, we compared amph-AuNP signal associated with cells after serial washing steps (SI Fig. 2) . Signal decreased by ~30% after one washing step in PBS and did not
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We next compared the behavior of these anionic amph-AuNPs to the interaction of amphiphilic gold nanoparticles bearing a cationic charge. Cationic amph-AuNPs coated with eleven-carbon alkanethiol ligands terminated by trimethylamine (TMA) groups were prepared with a gold core diameter of 5.7 ± 1.5 nm. In clear contrast to the sulfonate-functionalized amph-AuNPs (Fig. 1b) , BODIPY-labeled TMA AuNPs aggregated significantly on and around erythrocytes, reminiscent of the aggregation reported by Li and Malmstadt for cationic particles that bind to and then extract protrusions of membrane lipids in contact with giant lipid vesicles (SI Fig. 23) . 50 In addition, incubation with TMA amph-AuNPs led to calcein leakage into many cells (SI Fig. 2 arrows) , indicating that the cationic nanoparticles induced membrane poration.
Since TMA particles are known to disrupt cell membranes by virtue of their cationic charge 51, 52 , it is likely that their charge and not their larger size was responsible for RBC membrane poration. In our previous work, we observed similar membrane disruption in dendritic cells treated with TMA particles of core sizes similar to amph-AuNPs. 38 The confocal analysis indicated that MUS:OT NPs appear to prefer a membraneassociated state and, since erythrocytes lack a nucleus or internal membranes, it is noteworthy that amph-AuNPs outlined the only cellular membrane present, the plasma hr at 37°C, then fixed, embedded, and sectioned them for electron microscopy ( Fig. 2) .
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At both time points, AuNPs were distinctly found associated with the cell surfaces, either directly opposed to the membrane or apparently embedded within it (Fig. 2a, b) .
Distinctly, no particles were found in the cytosol for either time point (Fig. 2c) . Further, at the highest resolution that we could achieve, it appeared that most of the MUS:OT NPs that decorated the membrane were embedded within it.
Given this confirmation that amph-AuNPs associate with RBCs, we next sought to determine the features of the cell surface that play a role in mediating AuNPmembrane interaction. Since erythrocytes are non-nucleated and free of other organelles, their plasma membrane has a key role in regulating both the structure and function of the entire cell. The erythrocyte membrane, which has been very well studied 53, 54 , is made up of three components (Fig. 3) . First, there is a dense glycocalyx on the external face, composed of the polysaccharide chains of glycolipids and glycoproteins capped by sialic acid molecules, which contribute to an overall negative charge. They are the first point of contact with other cells and any interacting nanomaterials. Second, the lipid bilayer of the membrane itself is composed of lipids and cholesterol and also up to 50% by mass of proteins, many of which have transmembrane domains. Third and finally, the spectrin-actin network of the underlying cytoskeleton is intimately and strongly associated with the membrane, creating a tension that controls an erythrocyte's unique mechanical properties that allow it to travel through the myriad vessels of the body's circulatory system. We sought to characterize the role of each of these three contributors to RBC surface properties in turn by treating To study the effect of the glycocalyx on MUS:OT interactions with the membrane, erythrocytes were treated either with neuraminidase to selectively remove only the sialic acids, or with a combination of neuraminidase, heparinase, and hyaluronidase to remove the entire sugar layer on the surface of the cells. 55, 56 When sialic acids were preferentially stripped, MUS:OT interactions increased significantly (2.2-fold) compared to unaltered cells treated with AuNPs, suggesting that the interaction of the anionic particles with the RBC membrane is substantially inhibited by these negatively-charged sugars ( Fig. 4a) . When the entire glycocalyx was removed, MUS:OT-membrane interaction increased only slightly further (2.6-fold compared to unaltered cells) ( Nanoscale Accepted Manuscript family [55] [56] [57] ), there was no significant difference in AuNP-membrane interaction following this treatment (Fig. 4b) . Collectively, these results suggest that the cell surface association observed by confocal and electron microscopy reflects favorable particle interactions with the cell membrane itself rather than with cell surface proteins or components of the glycocalyx.
We next tested the role of cytoskeletal-membrane tension on MUS:OT particle interactions with the RBC membrane, by treating RBCs with iodoacetamide and inosine to deplete ATP and thus increase cytoskeletal-membrane tension, or by treating the cells with calyculin A and phorbol 12-myristate 13-acetate (PMA) to activate protein kinase C (PKC), disrupt the spectrin-actin network, and decrease this tension. 58, 59 There was no difference in particle association by cells when ATP was depleted to increase tension, but association increased by 1.6-fold when the spectrin-actin network was disrupted to decrease tension (Fig. 4c) . Since the drugs for this latter treatment were introduced in DMSO, we also treated cells with amph-AuNPs in the presence of the same concentration of DMSO (1 vol%) alone, and saw no effect of the vehicle alone (data not shown). Thus, amph-AuNPs may prefer bilayer areas where cytoskeletalmembrane tension is low.
These experiments with erythrocytes indicated that the surface glycocalyx and charge play significant roles in amph-AuNP/membrane interactions, but the living cell has a highly complex surface structure where many components may simultaneously participate in governing the outcome of nanoparticle binding. Thus, we next moved to a synthetic system of model membranes to better understand and confirm the roles of specific cell surface lipids and sugars on amph-AuNP/membrane association. We interactions decreased 34% when cholesterol was added, but further addition of DOPE or sphingomyelin had little further impact on particle absorption by the GMVs (BODIPY- Finally, to assess the effect of temperature on these interactions, we compared amph-AuNP uptake in sphingomyelin-or GM1-containing GMVs at 22°C and 37°C (Fig.   5e ). We compared these to all-DOPC GMVs incubated with amph-AuNPs at 22°C as a 'gold standard' for GMVs absorbing high levels of amphiphilic particles. GMVs containing SM but lacking GM1 showed lower particle absorption at 22°C compared to the DOPC control vesicles, but at 37°C, which is at the T m of SM, amph-AuNP absorption to the membrane-mimic GMVs was comparable to DOPC controls. By contrast, RBC membrane mimics including GM1 showed a substantially lower increase in particle association that increased only 2.4-fold moving from 22°C to 37°C, consistent with our whole-cell experiments that suggested the glycocalyx plays an important role in limiting nanoparticle absorption into the cell plasma membrane. Therefore, we conclude that, while increasing temperature to the physiological range overcomes the particleblocking effect of SM, it has only a small influence on the effect of GM1. These results suggest that while erythrocyte membrane decoration may be wholly sufficient with a glycocalyx intact, perhaps co-administration of neuraminidase (or similar sialic acidaltering molecule) attached to the nanoparticle could be employed to achieve higher levels of NP-membrane interactions.
Conclusions
Employing erythrocytes as 'pharmacytes' -cell-based carriers of therapeutic cargoes -is of great interest, but current techniques first require manipulation of cells ex vivo before autologous transfer in vivo.
Here, we present a system of amphiphilic AuNPs that, by virtue of their core size and surface ligand hydrophobicity, are able to embed within erythrocyte membranes. We have shown that amph-AuNP-membrane embedding depends on membrane fluidity and the glycocalyx, and particle association with RBC membranes is promoted by increasing temperature (up to physiological levels) or when the glycocalyx in general or the sialic acids in particular are removed.
Our studies with model lipid membranes further suggest that the high T m lipid SM plays a key role in modulating amph-AuNP association with RBC membranes at room temperature but GM1 plays a more important role at physiological temperature. These results inform design characteristics needed to achieve optimal membrane-embedding by amphiphilic nanoparticles. Altogether, these results suggest that these amph-AuNPs 
Experimental Materials
HAuCl 4 salt, OT ligand, and calcein were purchased from Sigma. BODIPY 630/650-X succinimidyl ester was purchased from Invitrogen. MUS ligands were prepared in-house with a method described previously. 38 Amph-AuNPs were also prepared in-house as described previously. 37 Neuraminidase, hyaluronidase, and heparinase were purchased from Sigma, as were trypsin and chymo-trypsin. Calyculin
A, phorbol 12-myristate 13-acetate (PMA), iodoacetamide, and inosine were also purchased from Sigma. All lipids and cholesterol were purchased from Avanti Polar Lipids.
AuNP synthesis, characterization, & labeling
We used a modified one-phase Brust-Schiffrin synthesis to prepare amphAuNPs.
0.07 mg/mL at 37°C with continuous rotation. Fluorescence was analyzed by flow cytometry without washing of excess AuNPs at 5 min, 30 min, 1 hr, 3 hr, and 24 hr. All erythrocytes were obtained with approval by and in accordance with MIT guidelines.
Stripping of sialic acids & glycocalyx
To selectively strip the sialic acids off the surface of the membrane, erythrocytes were treated with neuraminidase at 0.1 U/mL for 2 hr at 22°C with continuous rotation.
To strip the entire glycocalyx off the surface of the membrane, erythrocytes were treated with a combination of neuraminidase at 0.1 U/mL, heparinase at 5 U/mL, and hyaluronidase at 50 µg/mL for 2 hr at 22°C with continuous rotation. After treatment, cells were pelleted, excess enzymes were removed, and amph-AuNPs were added.
Removal of membrane proteins
To remove membrane glycoproteins, erythrocytes were co-treated with trypsin and chymo-trypsin at 1 mg/mL each at 22°C with continuous rotation. After treatment, cells were pelleted, excess enzymes were removed, and amph-AuNPs were added.
Increasing/decreasing cytoskeletal-membrane tension
To deplete ATP and increase cytoskeletal-membrane tension, erythrocytes were treated with a medium of 6 mM iodoacetamine and 10 mM inosine in PBS without glucose for 3 hr at 22°C with continuous rotation. After treatment, cells were pelleted, and initial treatment volumes were removed. Amph-AuNPs were then added in the same ATP depletion buffer.
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To disrupt spectrin/actin networks and decrease cytoskeletal-membrane tension, erythroctyes were treated first with 0.2 µM calyculin A for 30 min at 22°C. Following this incubation, cells were pelleted, treatment medium was removed, and PMA was added for 90 min also at 22°C. Samples were rotated continuously during these incubations.
Finally, cells were pelleted, treatment volumes were removed, and amph-AuNPs were added.
GMV synthesis & preparation
To synthesize GMVs, lipid stocks in chloroform were added to glass scintillation vials, where total lipid was 1 µmole per vial. When fluorescent lipid tracers were necessary to label GMVs, dyes were added at 0.1-0.5 mol%. Chloroform was allowed to evaporate overnight at 22°C, in order to form lipid films on glass. Uncapped vials were then incubated in a water bath at 70°C for > 6 hr, and this step allowed these films to hydrate without immersion in solution. Sucrose buffer (50 mM in water or PBS) was then added at 2 mL per vial, and vials were capped and further incubated at 70°C overnight, allowing GMVs to form. GMVs were gently harvested with minimal agitation or mixing the following day, after first cooling to 22°C.
For the outer leaflet set (Fig. 4c) , the following formulations were used: 1) all-DOPC, 2) 75% DOPC/25% cholesterol, 3) 68% DOPC/7% DOPE/25% cholesterol, 4) 41% DOPC/7% DOPE/25% cholesterol/27% SM, and 5) 31% DOPC/27% SM/7% DOPE /25% cholesterol/10% GM1. For the pair-wise GMV set (Fig. 4d) , the following
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Confocal microscopy
For erythrocytes, 4 million cells were added to 200 µL per well of an 8-well
LabTek chamber (Nunc). Calcein was added at 20 µg/mL and BODIPY-MUS:OT 2:1 amph-AuNPs were added at 0.28 mg/mL. Treatment medium was prepared before the addition of cells and samples were rocked back and forth gently without mixing or agitation with a pipette. Samples were imaged with a LSM 510 confocal microscope (Carl Zeiss). Z-stacks were collected using an optical slice thickness of 1 µm, and images were analyzed with Zeiss LSM software.
For GMVs, confocal samples were prepared in 8-well LabTek chambers (Nunc) and, prior to adding GMVs, we first prepared solutions of 50 mM glucose in water with BODIPY-MUS:OT 2:1 amph-AuNPs at 0.07 mg/mL. GMV harvests in sucrose were mixed 1-2x with a pipette and added at a 1:4 ratio in a sample well. Notably, samples were only rocked back and forth after preparation and there was no additional mixing of GMVs with AuNPs in the well. Samples were incubated 1-3 hr at 22°C, unless otherwise noted. Samples were then imaged with a LSM 510 confocal microscope (Carl Zeiss). Z-stacks were collected using an optical slice thickness of 1 µm, and images were analyzed with Zeiss LSM software.
Flow cytometry
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Cell electron microscopy
For cell EM, cell fixative was first prepared as 2.5% gluteraldehyde, 3% paraformaldehyde with 5% sucrose in 0.1M sodium cacodylate buffer (pH 7. Sections were cut on a Reichert Ultracut E microtome with a Diatome diamond knife at a thickness setting of 50 nm. The sections were examined using a FEI Tecnai Spirit at 80KV and photographed with an AMT CCD camera.
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SI Figure 3.
Erythrocytes co-treated with calcein at 50 µg/mL and BODIPY-TMA as control NPs. Scale bars 50 µm. Table 1 . Mean core size and st. dev. for amph-AuNP batches A-C used in this study.
SI
